GS HCPCS - DOSAGE OF ERYTHROPOIETIN STIMULATING AGENT HAS BEEN REDUCED AND MAINTAINED IN RESPONSE TO HEMATOCRIT OR HEMOGLOBIN LEVEL

Code Information

  • HCPCS Code: GS
  • Sequence Number: 0010
  • Short Description: Epo/darbepoietin reduced 25%
  • Long Description: Dosage of erythropoietin stimulating agent has been reduced and maintained in response to hematocrit or hemoglobin level
  • Date Added: 1/1/2006
  • Action Code: N - No maintenance for this code
  • Action Effective Date: 1/1/2013
  • Classification: Temporary Procedures & Professional Services
  • Coding System: HCPCS

Code Type

  • Berenson-Eggers Type Of Service Code: N/A
  • Type Of Service Code:
      N/A

    Billing Information

    • Pricing Indicator Code:
        N/A
      • Multiple Pricing Indicator Code: N/A
      • Coverage Issues Manual Reference Section Number:
          N/A
        • Medicare Carriers Manual Reference Section Number:
          • 4273.1
        • Coverage Code: D - Special coverage instructions apply

        HCPCS Record

        Field Name Field Value
        Healthcare Common Procedure Coding System Code GS
        HCPCS Sequence Number 0010
        HCPCS Record Identification Code 7 - First line of modifier record also contains detail information in positions 92-275
        HCPCS Long Description Dosage of erythropoietin stimulating agent has been reduced and maintained in response to hematocrit or hemoglobin level
        HCPCS Short Description Epo/darbepoietin reduced 25%
        HCPCS Medicare Carriers Manual Reference Section Number 1 4273.1
        HCPCS Coverage Code D - Special coverage instructions apply
        HCPCS Code Added Date 1/1/2006
        HCPCS Action Effective Date 1/1/2013
        HCPCS Action Code N - No maintenance for this code

        Download Record

        Download this CLIA record record in Text format: Export

        Download this CLIA record record in Excel (CSV) format: Export

        Download this CLIA record record in XML format: Export

        This page was last updated on: 7/1/2024